Agebox iKids-Growth (Night Formula), 60-count bottles
Recalled by Agebox
Drug recall
Agebox
Class II — moderate
Using this product might cause a temporary or medically reversible health problem. The chance of serious harm is low.
Agebox has recalled Agebox iKids-Growth (Night Formula), 60-count bottles, according to data published by the U.S. Food and Drug Administration (FDA). The recall was reported on March 4, 2026 and was initiated on October 28, 2025. It is classified as a Class II recall, which means using this product might cause a temporary or medically reversible health problem. The chance of serious harm is low.
Below is a plain-English summary of what was recalled, why it was recalled, how to tell whether you have the affected product, and what steps you can take. For the complete and most current details, you can view the FDA record linked further down this page.
What was recalled?
This recall covers Agebox iKids-Growth (Night Formula), 60-count bottles, with approximately N/A affected. The company behind the recall is Agebox, based in Wilmington, DE. The FDA describes the product as: “Agebox iKids-Growth (Night Formula), 60-count bottles, Manufactured Exclusively For: AGEBOX Inc., Wilmington, DE 19801 USA, UPC 850065597027”
Why was Agebox iKids-Growth (Night Formula), 60-count bottles recalled?
According to the FDA, the stated reason for the recall is: “Marketed Without an Approved NDA/ANDA: presence of undeclared ibutamoren.” In plain terms, this recall relates to an undeclared ingredient or allergen.
An undeclared ingredient means a food contains something — often a major allergen such as milk, eggs, soy, wheat, peanuts, or tree nuts — that is not listed on the label. For most people this is not dangerous, but for someone with a food allergy or sensitivity it can trigger a serious reaction. Accurate labeling is required so that people can avoid ingredients they need to stay away from.
What should you do?
If you think you may have bought Agebox iKids-Growth (Night Formula), 60-count bottles, compare it against the product description and identifying codes (Lot # 23101202 exp 09/2026, 24080802 exp 07/2027, and 25020702 exp 01/2028) before using it. This recall is currently listed as ongoing.
The general guidance for a matching product is to stop using it and follow the instructions in the official FDA recall notice, which may include a repair, replacement, refund, or safe disposal. When in doubt, contact Agebox or your local health authority.
About this recall
This recall was distributed in DE. RecallRadar summarizes recall information from public FDA data to make it easier to understand. We are an independent service and are not affiliated with the FDA or any government agency, so please always refer to the official source for the authoritative record — and note the “last synced” date shown on this page, since recall details can change over time.
Full recall details
- Status
- Ongoing
- Date reported
- March 4, 2026
- Recall started
- October 28, 2025
- Distributed in
- DE
What you can do
Check whether any product you have matches the description and codes above. If it does, stop using it and follow the instructions in the official recall notice. When in doubt, contact the company or your local health authority.
Quick answers
Why was Agebox iKids-Growth (Night Formula), 60-count bottles recalled?+
According to the FDA: Marketed Without an Approved NDA/ANDA: presence of undeclared ibutamoren
How serious is this recall?+
Class II — moderate. Using this product might cause a temporary or medically reversible health problem. The chance of serious harm is low.
What should I do if I have Agebox iKids-Growth (Night Formula), 60-count bottles?+
Compare your product against the description and identifying codes on this page. If it matches, stop using it and follow the instructions in the official recall notice — this usually means returning it for a refund or discarding it. When in doubt, contact the company or your local health authority.
Opens the U.S. Food and Drug Administration (FDA) data for this recall.
Recall number: D-0345-2026. Information last synced from the FDA on July 5, 2026.